Drug Channels Archive for December, 2025

Click a link below to view the mailing archive as if it had been sent to you.

2025-12-16 08:20		Drug Channels - 340B Hit $81 Billion in 2024: Why CMS and the IRA Are Poised to Cool the Program's Runaway Growth (VIDEO)
2025-12-15 07:47		Drug Channels - 340B Hit $81 Billion in 2024 (+23%): Why CMS and the IRA Are Poised to Cool the Program's Runaway Growth
2025-12-12 07:47		Drug Channels - Gross-to-Net Bubble Hits $356B in 2024—But Growth Slows to 10-Year Low (rerun)
2025-12-11 07:47		Drug Channels - The Future of Buy-and-Bill Market Access: Five Drivers of Wholesalers' Vertical Integration with Physician Practices (rerun)
2025-12-10 07:47		Drug Channels - Who Will Pay for Prescription Drugs in 2033: DCI's Takeaways from the Latest Government Forecasts (rerun)
2025-12-09 07:51		Drug Channels - Follow the 340B Dollar: Senator Cassidy Exposes How CVS Health and Walgreens Profit as 340B Contract Pharmacies (rerun)
2025-12-08 07:47		Drug Channels - How Large PBMs Make Money Today: A 2025 Drug Channels Update (rerun)
2025-12-05 07:47		Drug Channels - Closing the Specialty Access Gap: How GoodRx Turns Intent Into Therapy Starts
2025-12-04 07:47		Join me next Friday for the Drug Channels Outlook 2026 (live webinar & replay)
2025-12-02 07:47		Drug Channels - List Price Reductions Will Deflate the Gross-to-Net Bubble–and Threaten Pharmacy and 340B Profits from IRA-Negotiated Drugs